Atrial fibrillation (AFib) can affect life expectancy due to factors that include age, underlying health conditions, race, and how this common cardiac arrhythmia—or abnormal heart rhythm— is treated.

This no-implant atrial shunt could offer an effective treatment for heart failure. [Image courtesy of Alleviant Medical] Alleviant Medical announced today that it raised $90 million to fund the ...

According to their website, the WATCHMAN is a one-time implant for people with non-valvular atrial fibrillation to reduce stroke risk for those who cannot take long-term blood thinners.

Drinking coffee may improve cognitive performance in atrial fibrillation patients, according to a Swiss study. Higher coffee intake was associated with better test scores and reduced inflammation, ...

The US Food and Drug Administration (FDA) has granted Alleviant Medical an investigational device exemption (IDE), enabling the company to begin a pivotal trial evaluating its atrial shunt ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study.

Alleviant has developed a device that leaves behind no permanent implant and is aimed at chronic, symptomatic heart failure patients despite appropriate medical therapy. The device is inserted ...

Independence Health System’s Westmoreland Hospital announced that its Heart Lung and Vascular Institute specialists ...